Improving the solubility and bioavailability of poorly soluble APIs remains one of the toughest challenges in pharmaceutical ...

Immune checkpoint inhibitors (ICIs) have revolutionized the field of cancer immuno-oncology.  ICIs act on cancer cells by ...